Barw Barw Medical Journal 2960-1959 2024 02 01 Cancer Publications in One Year (2023): A Cross-Sectional Study 10.58742/g9q9t715 eng Ervin Mingomataj Mother Theresa School of Medicine and Medicine University of Tirana - Faculty of Medical-Technical Sciences, Tirana – Albania. Ervin.Mingomataj@gmail.com Marsida Krasniqi Department of Medical Technical Sciences, University Aleksander Moisiu, Durres, Albania. Our Lady of Good Counsel, Tirana, Albania. Marsida.Krasniqi@gmail.com Kreshnike Dedushi Clinical of Radiology, Faculty of Medicine University of Prishtina, University Clinical Center of Kosovo, Prishtina, Kosovo. Kreshnike.Dedushi@gmail.com Kapustin Andrey Sergeevich North Caucasus Federal University, Pushkin Street, Stavropol, Russia. Kapustin.Sergeevich@gmail.com Davor Kust Department of Oncology and Nuclear Medicine, Sestre milosrdnice University Hospital Center, Zagreb, Croatia. Davor.Kust@gmail.com Abdullah Abdulrahman Qadir Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Kurdistan, Iraq. Abdulhhah.Qadir@gmail.com Aland S. Abdullah College of Medicine, University of Sulaimani, Madam Mitterrand, Sulaymaniyah, Kurdistan, Iraq. alandsalihh@gmail.com Masty K. Ahmed Smart Health Tower, Madam Mittrand, Sulaimani, Kurdistan, Iraq. Masty.Ahmed@gmail.com Gona M. Fatah Department of Biology, College of Education, University of Sulaimani, Madam Mitterrand, Sulaymaniyah, Kurdistan, Iraq. Gona.Fatah@gmail.com 2024 01 02 Introduction Cancer is a disease where transformed cells undergo uncontrolled division and survival. The incidence of cancer and hence its burden is on the rise. This study aims to evaluate the scientific studies published on cancer in the year 2023. Methods A cross-sectional study included the cancer papers that were published in the year 2023. After extracting the data from the Google Scholar engine, they were all gathered and recorded in a Microsoft Excel 2010 sheet. All of the data were rigorously evaluated, calculated, and then presented as frequencies and percentages. Results A total of 181,189 studies published in 2023 on cancers and their different types were seen as eligible to be included in this study. Amongst them, studies on breast cancers with 31,000 studies were the most common whereas subglottic cancers with only 7 studies were the least common in that year. Conclusion The gap between the incidence rate of each type of cancer and the number of studies published on each type makes it harder to thoroughly grasp the nature of the disease to its utmost extent.